MDS research criteria for prodromal Parkinson's diseaseDaniela Berg, Günther Deuschl, Matthew Stern et al.|Movement Disorders|2015Cited by 1.3k
Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot StudyMichelle M. Mielke, Inga Liepelt‐Scarfone, Norman J. Haughey et al.|PLoS ONE|2013Cited by 238
Health-Related Quality of Life in patients with Parkinson's disease—A systematic review based on the ICF modelJanet M.T. van Uem, Walter Maetzler, Meg E. Morris et al.|Neuroscience & Biobehavioral Reviews|2015Cited by 212
The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's diseaseAlexandra Gaenslen, Daniela Berg, Irene Swid et al.|Movement Disorders|2011Cited by 196
Movement disorder society criteria for clinically established early Parkinson's diseaseDaniela Berg, Ronald B. Postuma, Charles H. Adler et al.|Movement Disorders|2018Cited by 172